AI Verdict
Confidence: HighMarket is attractive but StackNinja demonstrates critical failures: no trust signals, weak founder execution, and $45 MRR after launch indicates poor product-market fit. Enter only with strong medical credibility and better go-to-market strategy.
Financials
Buildability
StackNinja | Health protocols
Protocolos de suplementos personalizados e baseados em ciência, de acordo com seus objetivos e resultados de exames de sangue
Personalized supplement protocols with blood test integration, struggling at $45 MRR with weak validation.
None currently - no proprietary data, network effects, or strong brand
- Health-conscious individuals (25-45) who track biomarkers and want data-driven supplement guidance
- Biohackers and quantified-self enthusiasts
- No visible clinical validation
- Lack of practitioner integration
- No ongoing monitoring features
- Weak educational content
- MD/PhD-reviewed protocols
- Insurance integration
- Continuous biomarker monitoring
- Supplement fulfillment partnership
Low - Health protocols require high trust, limited sharing incentives, no visible referral mechanisms
- Regulatory (FDA/health claims)
- Liability for supplement recommendations
- High customer acquisition costs in health space
- Strong incumbents with better funding
$15k-30k for MVP (development + initial compliance)
- Blood test results parser/upload
- Supplement recommendation engine
- Goal-based protocol builder
- User dashboard with progress tracking
Skip: Mobile apps, Advanced analytics, Integration with multiple lab providers